Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma

by Ferrucci, Pier Francesco, Gandini, Sara, Cocorocchio, Emilia, Pala, Laura, Baldini, Federica, Mosconi, Massimo, Antonini Cappellini, Gian Carlo, Albertazzi, Elena, Martinoli, Chiara
Published in Oncotarget (2017)

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib

by Caporali, Simona, Alvino, Ester, Lacal, Pedro Miguel, Ruffini, Federica, Levati, Lauretta, Bonmassar, Laura, Scoppola, Alessandro, Marchetti, Paolo, Mastroeni, Simona, Antonini Cappellini, Gian Carlo, D’Atri, Stefania
Published in Oncotarget (2017)

Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker

by Cesati, Marco, Scatozza, Francesca, D’Arcangelo, Daniela, Antonini-Cappellini, Gian Carlo, Rossi, Stefania, Tabolacci, Claudio, Nudo, Maurizio, Palese, Enzo, Lembo, Luigi, Di Lella, Giovanni, Facchiano, Francesco, Facchiano, Antonio
Published in Cancers (Basel) (2020)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma

by Audrito, Valentina, Managò, Antonella, Zamporlini, Federica, Rulli, Eliana, Gaudino, Federica, Madonna, Gabriele, D'Atri, Stefania, Antonini Cappellini, Gian Carlo, Ascierto, Paolo Antonio, Massi, Daniela, Raffaelli, Nadia, Mandalà, Mario, Deaglio, Silvia
Published in Oncotarget (2018)

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

by Caporali, Simona, Amaro, Adriana, Levati, Lauretta, Alvino, Ester, Lacal, Pedro Miguel, Mastroeni, Simona, Ruffini, Federica, Bonmassar, Laura, Antonini Cappellini, Gian Carlo, Felli, Nadia, Carè, Alessandra, Pfeffer, Ulrich, D’Atri, Stefania
Published in J Exp Clin Cancer Res (2019)

Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab

by Narducci, Maria Grazia, Tosi, Anna, Frezzolini, Alessandra, Scala, Enrico, Passarelli, Francesca, Bonmassar, Laura, Monopoli, Alessandro, Accetturi, Maria Pina, Cantonetti, Maria, Antonini Cappellini, Gian Carlo, De Galitiis, Federica, Rosato, Antonio, Picozza, Mario, Russo, Giandomenico, D’Atri, Stefania
Published in Front Immunol (2020)

Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

by Queirolo, Paola, Dozin, Beatrice, Morabito, Anna, Banelli, Barbara, Piccioli, Patrizia, Fava, Cristiana, Leo, Claudio, Carosio, Roberta, Laurent, Stefania, Fontana, Vincenzo, Ferrucci, Pier Francesco, Martinoli, Chiara, Cocorocchio, Emilia, Battaglia, Angelo, Ascierto, Paolo A., Capone, Mariaelena, Simeone, Ester, De Galitiis, Federica, Pagani, Elena, Antonini Cappellini, Gian Carlo, Marchetti, Paolo, Guida, Michele, Tommasi, Stefania, Mandalà, Mario, Merelli, Barbara, Quaglino, Pietro, Fava, Paolo, Guidoboni, Massimo, Romani, Massimo, Spagnolo, Francesco, Pistillo, Maria Pia
Published in Front Immunol (2017)

Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Interg...

by Queirolo, Paola, Dozin, Beatrice, Morabito, Anna, Banelli, Barbara, Piccioli, Patrizia, Fava, Cristiana, Leo, Claudio, Carosio, Roberta, Laurent, Stefania, Fontana, Vincenzo, Ferrucci, Pier Francesco, Martinoli, Chiara, Cocorocchio, Emilia, Battaglia, Angelo, Ascierto, Paolo A., Capone, Mariaelena, Simeone, Ester, De Galitiis, Federica, Pagani, Elena, Antonini Cappellini, Gian Carlo, Marchetti, Paolo, Guida, Michele, Tommasi, Stefania, Mandalà, Mario, Merelli, Barbara, Quaglino, Pietro, Fava, Paolo, Guidoboni, Massimo, Romani, Massimo, Spagnolo, Francesco, Pistillo, Maria Pia
Published in Front Immunol (2018)